Sandy Spring Bank Lowers stake in Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) : Sandy Spring Bank reduced its stake in Johnson & Johnson by 6.28% during the most recent quarter end. The investment management company now holds a total of 106,586 shares of Johnson & Johnson which is valued at $13,179,359 after selling 7,147 shares in Johnson & Johnson , the firm said in a disclosure report filed with the SEC on Aug 9, 2016.Johnson & Johnson makes up approximately 1.46% of Sandy Spring Bank’s portfolio.

Other Hedge Funds, Including , Eaton Vance Management boosted its stake in JNJ in the latest quarter, The investment management firm added 698,468 additional shares and now holds a total of 7,305,185 shares of Johnson & Johnson which is valued at $904,162,747. Johnson & Johnson makes up approx 2.53% of Eaton Vance Management’s portfolio.Delaney Dennis R boosted its stake in JNJ in the latest quarter, The investment management firm added 10 additional shares and now holds a total of 23,251 shares of Johnson & Johnson which is valued at $2,877,776. Johnson & Johnson makes up approx 5.99% of Delaney Dennis R’s portfolio.Keating Investment Counselors Inc boosted its stake in JNJ in the latest quarter, The investment management firm added 425 additional shares and now holds a total of 81,561 shares of Johnson & Johnson which is valued at $10,105,408. Johnson & Johnson makes up approx 4.97% of Keating Investment Counselors Inc’s portfolio.Wendell David Associates Inc reduced its stake in JNJ by selling 18,450 shares or 13.4% in the most recent quarter. The Hedge Fund company now holds 119,233 shares of JNJ which is valued at $14,920,818. Johnson & Johnson makes up approx 2.85% of Wendell David Associates Inc’s portfolio.Baker Boyer National Bank boosted its stake in JNJ in the latest quarter, The investment management firm added 123 additional shares and now holds a total of 9,831 shares of Johnson & Johnson which is valued at $1,209,213. Johnson & Johnson makes up approx 5.40% of Baker Boyer National Bank’s portfolio.

Johnson & Johnson opened for trading at $120.5 and hit $121.33 on the upside on Wednesday, eventually ending the session at $121.31, with a gain of 0.81% or 0.98 points. The heightened volatility saw the trading volume jump to 1,04,42,818 shares. Company has a market cap of $331,889 M.

On the company’s financial health, Johnson & Johnson reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.68. The company had revenue of $18482.00 million for the quarter, compared to analysts expectations of $17985.80 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.

Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by UBS on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 137 from a previous price target of $126 .Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 133 from a previous price target of $125 .Standpoint Research Initiated Johnson & Johnson on May 20, 2016 to “Sell”, Price Target of the shares are set at $94.

Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Company’s primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Company’s research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.

Leave a Reply

Johnson & Johnson - Is it time to Sell?

Top Brokerage Firms are advising their investors on Johnson & Johnson. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.